IcareLife

IcareLife A Legacy of Care, A Future of Wellness

developed produce and sales of a series of natural & nutrient healthcare product 。
『健康、智慧、财富、』
Wellness, Wisdom, Wealth

✨ A Life Changed Through Gene Therapy ✨1st November 2025 • 2nd National Conference for Thalassaemics and CarersStanding ...
01/12/2025

✨ A Life Changed Through Gene Therapy ✨
1st November 2025 • 2nd National Conference for Thalassaemics and Carers

Standing on the left is Mr. Ricky Koh, Founder of iCare Biotech.
On the right is Malaysia’s first cured Beta Thalassaemia patient under iCare’s gene therapy program. 💚

This brave young man took the stage on the day to share his journey — from years of blood transfusions to complete freedom after receiving gene therapy. His recovery marks a new chapter of life, filled with possibilities and hope.

Moments like this remind us why we work tirelessly to expand access to advanced gene therapy across Asia — so patients and families can see a future beyond lifelong medical limitations.

A historic day not just for iCare, but for the Thalassaemia community in Malaysia and beyond. 🌏✨

Who is eligible for SMA gene therapy?Many families feel uncertain — and the process can be overwhelming.This simple bili...
19/11/2025

Who is eligible for SMA gene therapy?
Many families feel uncertain — and the process can be overwhelming.
This simple bilingual guide explains the core criteria, the Early Access Program (EAP), and how specialists determine eligibility.

Every child is unique, and early diagnosis remains one of the most important factors for meaningful outcomes.
If you are exploring treatment options for your child, we are here to support you with clear, compassionate guidance at every step — from eligibility assessment to post-treatment follow-up.

Take the first step today. Every day counts for genetic conditions. 💛

Who is eligible for SMA gene therapy?Many families feel uncertain — and the process can be overwhelming.This simple bili...
19/11/2025

Who is eligible for SMA gene therapy?
Many families feel uncertain — and the process can be overwhelming.
This simple bilingual guide explains the core criteria, the Early Access Program (EAP), and how specialists determine eligibility.

Every child is unique, and early diagnosis remains one of the most important factors for meaningful outcomes.
If you are exploring treatment options for your child, we are here to support you with clear, compassionate guidance at every step — from eligibility assessment to post-treatment follow-up.

Take the first step today. Every day counts for genetic conditions. 💛

Before our official partnership signing, our team and Lantu Biopharma’s CEO visited leading hospitals in Thailand to dis...
17/11/2025

Before our official partnership signing, our team and Lantu Biopharma’s CEO visited leading hospitals in Thailand to discuss early access gene therapy.

These meaningful discussions laid the foundation for today’s regional collaboration under the Gene Therapy Early Access Program (EAP). 💚

What is SMA Gene Therapy?A one-time treatment designed to replace the missing SMN1 gene — protecting motor neurons and h...
12/11/2025

What is SMA Gene Therapy?

A one-time treatment designed to replace the missing SMN1 gene — protecting motor neurons and helping children gain strength.

Because every movement matters, and early diagnosis makes all the difference. 💛

05/11/2025

Every movement tells a story of resilience.
Behind every SMA patient is a family that never gives up.

We're here to make sure early access isn’t just a dream — but a possibility. 💛

SMA 基因治疗,患者的新希望
05/11/2025

SMA 基因治疗,患者的新希望

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

FREE FROM BLEEDING IS POSSIBLE?YES, ONE-TIME INJECTION — LIFETIME FREE FROM BLEEDING.GET IN TOUCH WITH US!रक्तस्रावबाट म...
05/11/2025

FREE FROM BLEEDING IS POSSIBLE?

YES, ONE-TIME INJECTION — LIFETIME FREE FROM BLEEDING.
GET IN TOUCH WITH US!

रक्तस्रावबाट मुक्त हुनु सम्भव छ?

हो, एक पटकको इन्जेक्शनले — जीवनभर रक्तस्रावबाट मुक्ति।
आजै हामीसँग सम्पर्क गर्नुहोस्!



A New Era of Hope for Adult Hemophilia B Patients

At Icare, we are proud to introduce (rAAV5-F9) gene therapy, an innovative treatment designed to transform the lives of Hemophilia B patients. With just one treatment, patients can be free from bleeding episodes, restoring health and improving quality of life.

वयस्क हेमोफिलिया B बिरामीहरूका लागि नयाँ आशाको युग

Icare मा, हामी गर्वका साथ प्रस्तुत गर्छौं (rAAV5-F9) जीन थेरापी, जुन हेमोफिलिया B बिरामीहरूको जीवन परिवर्तन गर्न डिजाइन गरिएको एक नवीन उपचार हो। केवल एक पटकको उपचारले बिरामीहरूलाई रक्तस्रावका घटनाबाट मुक्त गराउन सक्छ, स्वास्थ्य पुनर्स्थापना गर्न र जीवनको गुणस्तर सुधार गर्न सहयोग पुर्‍याउँछ।



Why Choose Our Therapy?

• Proven safe
• Highly effective in stopping bleeding
• Cost-accessible through our Early Access Program (EAP)

हाम्रो उपचार किन छान्ने?

• सुरक्षित भएको प्रमाणित
• रक्तस्राव रोक्न अत्यन्त प्रभावकारी
• Early Access Program (EAP) मार्फत किफायती रूपमा उपलब्ध



Through the EAP, we make this life-changing therapy available at a reduced cost, ensuring timely support for patients who need it most.

This gene therapy is suitable only for patients aged 18 years and above.

EAP मार्फत, हामी यो जीवन परिवर्तन गर्ने उपचार कम लागतमा उपलब्ध गराउँछौं, जसले सबैभन्दा आवश्यक बिरामीहरूलाई समयमै सहयोग पुर्‍याउँछ।

यो जीन थेरापी १८ वर्ष वा सो भन्दा माथिका बिरामीहरूका लागि मात्र उपयुक्त छ।



More Information:

Please view Hemophilia YouTube link:
🔗 https://youtu.be/z_KSQeFtJgY
📩 Email: rickykoh@icare.com.my | icarebiotech@gmail.com
📱 WhatsApp: +60 10-232 3818
💬 LINE: Click here
💬 WeChat ID: rickykohth88



Join us in this movement to end bleeding and embrace a healthier future with gene therapy.
रक्तस्राव अन्त्य गर्ने यस अभियानमा सहभागी बनौं र जीन थेरापीसँग स्वस्थ भविष्यलाई स्वागत गरौं।




FREE FROM BLEEDING IS POSSIBLE ?
YES ,ONE TIME INJECTION ,LIFETIME FREE FROM BLEEDING.
GET IN TOUCH WITH US !

A New Era of Hope for adult Hemophilia B Patients

At Icare, we are proud to introduce (rAAV5-F9) gene therapy, an innovative treatment designed to transform the lives of Hemophilia B patients. With just one treatment, patients can be free from bleeding episodes, restoring health and improving quality of life.

Why choose our therapy?
• Proven safe
• Highly effective in stopping bleeding
• Cost-accessible through our Early Access Program (EAP)

Through the EAP, we make this life-changing therapy available at a reduced cost, ensuring timely support for patients who need it most.This Gene therapy only suitable for patient age above 18 years old
More information please view Hemophilia Youtube link :
https://youtu.be/z_KSQeFtJgY
📩 Email: rickykoh@icare.com.my | icarebiotech@gmail.com
📱 WhatsApp: +60 10-232 3818
💬 LINE: Click here
💬 WeChat ID: rickykohth88

Join us in this movement to end bleeding and embrace a healthier future with gene therapy.

# Vietnam hemophilia Thailand India Pakistan Jordan Bangladesh Africa

Hemophilia B adults and families — a new era of treatment is here.Living with Hemophilia B often means frequent bleeding episodes, regular infusions, and con...

05/11/2025

Harapan Baru bagi Pasien Talasemia yang Bergantung pada Transfusi (TDT)

Di Icare, kami bangga memperkenalkan terapi gen inovatif yang menawarkan solusi kuratif untuk talasemia yang bergantung pada transfusi. Dengan perawatan ini, pasien dapat mencapai kemandirian dari transfusi darah seumur hidup, yang mengarah pada peningkatan kesehatan dan kualitas hidup yang lebih baik.

Terapi kami:
• Aman
• Sangat efektif
• Terjangkau

Agar inovasi ini dapat diakses oleh lebih banyak pasien, kami menawarkannya melalui Program Akses Awal (EAP) — mengurangi biaya perawatan dan memastikan dukungan tepat waktu bagi mereka yang membutuhkan.

🔹 Ingin mempelajari lebih lanjut atau memulai perjalanan perawatan Anda?
🎥 Tonton video kami: Tautan YouTube
📧 Email: rickykoh@icare.com.my | icarebiotech@gmail.com
📱 WhatsApp: +60 10-232 3818
💬 LINE: ricky2323
📲 ID WeChat: rickykohth88

Kami dengan hangat mengundang Anda untuk bergabung dalam gerakan ini — untuk mengakhiri ketergantungan pada transfusi darah dan meraih masa depan yang lebih sehat dengan terapi gen autotemcel Vebeglogene.

⸻🌟 อิสรภาพจากการถ่ายเลือดเป็นไปได้แล้ว! 🌟ที่ Icare เรานำเสนอ นวัตกรรมการบำบัดยีน (Gene Therapy) สำหรับผู้ป่วย ธาลัสซีเมี...
05/11/2025



🌟 อิสรภาพจากการถ่ายเลือดเป็นไปได้แล้ว! 🌟

ที่ Icare เรานำเสนอ นวัตกรรมการบำบัดยีน (Gene Therapy) สำหรับผู้ป่วย ธาลัสซีเมียที่ต้องพึ่งพาการถ่ายเลือด (TDT)
💉 ไม่ต้องถ่ายเลือดตลอดชีวิตอีกต่อไป
💪 สุขภาพที่ดีขึ้น
🌈 อนาคตที่สดใส

✨ ปลอดภัย | มีประสิทธิภาพ | ราคาที่เข้าถึงได้

🎥 รับชมได้ที่ YouTube: https://youtu.be/R1RV6XWHGrI?si=-qqKTjki78WpgoH6

🔹 พร้อมให้บริการแล้ววันนี้ ผ่าน Early Access Program (EAP) เพื่อช่วยให้ผู้ป่วยที่ต้องการเข้าถึงการรักษาได้ง่ายขึ้น

📩 ติดต่อเราได้เลยวันนี้!
📧 rickykoh@icare.com.my | icarebiotech@gmail.com
📱 WhatsApp: +60 10-232 3818
💬 LINE: ricky2323 | WeChat: rickykohth88

👉 มาร่วมกันยุติการพึ่งพาการถ่ายเลือด ด้วย icare gene therapy – Vebeglogene autotemcel

🌟 Freedom from Blood Transfusions is Possible! 🌟

At Icare, we’re bringing a breakthrough gene therapy for transfusion-dependent thalassemia (TDT).
💉 No more lifelong transfusions.
💪 Better health.
🌈 Brighter future.

✨ Safe | Effective | Affordable
Please view YouTube :https://youtu.be/R1RV6XWHGrI?si=-qqKTjki78WpgoH6
🔹 Available now through our Early Access Program (EAP) — making treatment more accessible for patients in need.

📩 Get in touch today!
📧 rickykoh@icare.com.my | icarebiotech@gmail.com
📱 WhatsApp: +60 10-232 3818
💬 LINE: ricky2323 | WeChat: rickykohth88

👉 Join us in ending dependence on blood transfusions with icare gene therapy Vebeglogene autotemcel.

# Thailand Thalassemia # for Thalassemia MiddleEast
Dubai
HongKong Thalassemia Vietnam #
haematology society Pakistan
Bangladesh
Africa

If your child, your sibling, or even you are living with Transfusion-Dependent β-Thalassemia (TDT) or Hemoglobin E β-Thalassemia (HbE$\beta$ Thalassemia), yo...

Bringing Hope Through Gene Therapy 🌿Big news! 💫Icare Biotech has officially enter licensing agreement with Lantu Biophar...
01/11/2025

Bringing Hope Through Gene Therapy 🌿

Big news! 💫
Icare Biotech has officially enter licensing agreement with Lantu Biopharma (Guangzhou) to bring advanced Gene Therapy under the Early Access Program (EAP) — starting with Spinal Muscular Atrophy (SMA).

The signing ceremony took place in Bangkok, Thailand on 1st July 2025, witnessed by medical experts.

Together, we’re making groundbreaking treatments more accessible to those who need them most. 💚

Address

Block A-23A-1, Platinum Walk, 2 Jalan Langkawi
Kuala Lumpur
53300

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Telephone

+60341438863

Alerts

Be the first to know and let us send you an email when IcareLife posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to IcareLife:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram